Navigation Links
Amicus Therapeutics Announces First Quarter 2008 Financial Results
Date:5/13/2008

SFAS No. 123R. Amicus believes that excluding the

impact of expensing stock options better reflects the recurring

economic characteristics of its business.

(2) Other items -- Non-GAAP net loss and diluted net loss per common share

exclude other unusual or non-recurring items that are evaluated on an

individual basis. Amicus' evaluation of whether to exclude an item for

purposes of determining its non-GAAP financial measures considers both

the quantitative and qualitative aspects of the item, including, among

other things (i) its size and nature, (ii) whether or not it relates

to its ongoing business operations, and (iii) whether or not Amicus

expects it to occur as part of its normal business on a regular basis.

Items excluded for purposes of determining non-GAAP net loss and

diluted net loss per common share include deemed dividends, preferred

stock accretion, and changes in the fair value of warrant liability.

Conference Call and Webcast: First Quarter Financial Results

Amicus Therapeutics will host a conference call and webcast today, Tuesday, May 13, 2008, at 5:00 P.M. EDT to review financial results and recent developments. Interested participants and investors may access the teleconference call by dialing 877-397-0284 (U.S./Canada) or 719-325-4871 (international).

The webcast of the call can be accessed on the Investor section of Amicus' Web site at http://www.amicustherapeutics.com under Investors: Events and Presentations. Web participants are encouraged to go to the Web site 15 minutes prior to the start of the call to register, download and install any necessary software. After the live webcast, a replay will remain available in the Investors section of Amicus' Web site for 90 days.

A telephonic replay will also be available for seven days be
'/>"/>

SOURCE Amicus Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
2. Amicus Therapeutics Announces Third Quarter 2007 Financial Results
3. Meredith Martin Addy Named Chair of AIPLAs Amicus Committee
4. Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
5. Amicus Therapeutics to Host R&D Day
6. Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease
7. Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
8. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
9. Amicus Therapeutics to Present at the BIO CEO & Investor Conference 2008
10. Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease
11. Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... 28, 2015 First Harvest Financial ... leading source for advice to legal medical cannabis companies. ... and strategic planning to start-ups and entrepreneurs, First Harvest ... industry. , Wall Street veteran, Kevin Gillespie, has ... President and Portfolio Manager. Due to early success ...
(Date:4/28/2015)... (PRWEB) April 28, 2015 Spartan Bioscience ... founder, has been selected by the Ottawa Chamber of ... 40. Dr. Lem was selected from over 240 applicants ... involvement. , Prior to Spartan, Dr. Lem founded Plexagen ... DNA Genotek. He holds a Medical Degree from the ...
(Date:4/28/2015)... 2015 The Alliance for Clinical ... non-profit organization dedicated to transforming the medical products ... system for clinical research, announced today that it ... type of clinical research event in Boston, October ... is changing,” said Greg Koski, PhD, MD, Co-founder ...
(Date:4/27/2015)... VANCOUVER , April 27, 2015 /PRNewswire/ - iCo ... ICOTF), today reported financial results for the year ... are expressed in Canadian dollars and presented under ... year,s phase two DME results did not provide ... but extremely undervalued assets remain at iCo Therapeutics", ...
Breaking Biology Technology:Leading Medical Cannabis Advisor, First Harvest Financial, Welcomes Top Executives Aboard 2Leading Medical Cannabis Advisor, First Harvest Financial, Welcomes Top Executives Aboard 3Spartan Bioscience Announces Paul Lem Named Ottawa’s Top 40 Under 40 2ACRES Announces Innovative Clinical Research Event--SYNERGY 2ACRES Announces Innovative Clinical Research Event--SYNERGY 3ACRES Announces Innovative Clinical Research Event--SYNERGY 4iCo Therapeutics Announces Year End 2014 Financial Results 2iCo Therapeutics Announces Year End 2014 Financial Results 3iCo Therapeutics Announces Year End 2014 Financial Results 4
... Brinkmann /Eppendorf SOP, Standard Operating Procedure for Pipettes , , , ... , , , , , ... , , 2 ... , 3 , ...
... , , , Sample ... To extract RNA from washed and pelleted cultured cells, add 200 , ... Isothiocyanate, 25 mM Sodium Citrate, pH 7.0, 1 M b-Mercaptoethanol) , ... To directly extract RNA from cultured cells growing in monolayer, , ...
... , , , , Note: Genomic DNA ... mechanical forces. Use suitable large-bore pipet tips or equipment when , ... , Place a 1 cm tail sample ... may be stored at 20C. To minimize possible cross-contamination, , ...
Cached Biology Technology:Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 2Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 3Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 4Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 5Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 6Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 7Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 8Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 9Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 10Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 11Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 12Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 13Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 14Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 15Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 16Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 17Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 18Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 19Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 20Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 21Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 22Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 23Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 24Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 25Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 26Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 27Total RNA Isolation Protocol 1,2,3 2Total RNA Isolation Protocol 1,2,3 3Mouse Tail Genomic DNA Isolation Protocol(1) 2
(Date:4/2/2015)... Fingerprint Cards (FPC) has received ... the distributor World Peace Industrial Group (WPI), part of ... the major part of the shipments will take place ... smartphone manufacturers in China . The ... communicated revenue guidance of + 1 000 MSEK for 2015.  ...
(Date:3/31/2015)... March 31, 2015   Guidepoint , a leading ... the Post-Surgical Pain Management TRACKER, part of the ... trends in the medical device and therapeutics markets. The ... including treatment volumes, market share, and adoption rates across ... with joint surgery. The Post-Surgical Pain Management ...
(Date:3/24/2015)... ( http://www.researchandmarkets.com/research/kvdtcw/face_and_voice ) has announced the addition of the ... report to their offering. This report analyzes the worldwide ... following Segments: Face Biometrics, and Voice Biometrics. The report provides separate ... Japan , Europe , ... Africa , and Latin America . ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 4Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 5Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 6
... Fraser University statistician Rick Routledge will share his knowledge ... tell us about an area,s forest fire history, at ... is speaking at Forest Fires in Canada: Impacts of ... the 2012 American Association for the Advancement of Science ...
... commissioned the Dieticians Association of Australia to undertake systematic ... Guidelines for Australians. The primary aim was to undertake ... international literature from the year 2002 on the food-diet-health-disease ... sections in the report (pp 613-678) covered the evidence ...
... has found a way to give DNA-based computing better control ... computing with traditional silicon-based computing. The idea of using ... to perform computations is not new; scientists have been working ... to store much more data than conventional silicon-based computers, as ...
Cached Biology News:AAAS-SFU research: Controlling forest fires 2Comments by the International Scientific Forum on Alcohol Research 2Comments by the International Scientific Forum on Alcohol Research 3Researchers develop better control for DNA-based computations 2
adult...
EPH electrode, cathode, 1. Category: Electrophoresis Systems & Standards & Reagents, IEF & SDS-PAGE & 2-D Electrophoresis, Multiphor II Kits & Components and Accessories....
GENOMIPHI V2 DNA AMP KIT 25RXN, 1 EA. Category: Genomics DNA Amplification....
GENOMIPHI HY KIT 1000 RXN, 1 EA. Category: Genomics DNA Amplification....
Biology Products: